GLP-1 Receptor Agonists Linked to Lower Risk of Cirrhosis Progression in Early-Stage Metabolic Liver Disease, Study Finds Written By Medha Baranwal23 Sept 2024 8:00 AM ISTUSA: Recent findings from a cohort study have highlighted the potential benefits of GLP-1 receptor agonists (GLP-1 RAs) in managing patients with...
Metformin Associated with Lower Mortality Rates in Diabetes Patients With Heart Failure: Study Written By Medha Baranwal21 Sept 2024 9:00 AM ISTChina: A recent meta-analysis has provided compelling evidence regarding the use of metformin in patients with type 2 diabetes mellitus (T2DM) who...
Widely used test for gestational diabetes misses 70% of cases, finds research Dr. Kamal Kant Kohli21 Sept 2024 7:30 AM ISTWhen screening pregnant women for gestational diabetes, casual blood glucose testing misses 70% of the cases. This Kobe University study should...
Danish Study Reveals Connection Between Diabetic Neuropathy, Retinopathy, and Severe Periodontitis Written By Medha Baranwal21 Sept 2024 4:00 AM ISTDenmark: A cross-sectional analysis of Danish population-based data indicated that moderate and severe periodontitis was associated with certain...
Real-World Analysis of Tirzepatide Reveals Comparable Safety Profile to GLP-1 Receptor Agonists Written By Medha Baranwal20 Sept 2024 9:30 AM ISTItaly: A recent analysis of the FDA Adverse Event Reporting System (FAERS) database has provided new insights into the safety profile of tirzepatide...
Alprostadil Emerges as Effective Adjunct Therapy for Diabetes Mellitus and Peripheral Atherosclerosis: Study Written By Medha Baranwal20 Sept 2024 9:30 AM ISTChina: A recent study published in the Anatolian Journal of Cardiology has highlighted the efficacy of Alprostadil as an adjunct therapy for patients...
Study Finds Casual Blood Glucose Test Misses 70 Percent of Gestational Diabetes Cases Dr. Bhumika Maikhuri20 Sept 2024 7:45 AM ISTA study conducted at Kobe University reveals that 70% of the cases go unnoticed when casual blood sugar levels were measured to evaluate gestational...
SGLT2 inhibitors tied to lower risk of dementia, Parkinson's disease, suggests study Dr. Kamal Kant Kohli19 Sept 2024 8:45 PM ISTA class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September...
Hormone therapy can significantly reduce insulin resistance, shows new meta-analysis Dr. Kamal Kant Kohli19 Sept 2024 7:30 PM ISTMenopausal women are at greater risk of insulin resistance as a result of declining estrogen levels. Previous studies evaluating the potential...
Study Finds Link Between Moderate Level Coffee or Caffeine Intake and Risk Of Multiple Cardiometabolic Diseases Dr. Bhumika Maikhuri19 Sept 2024 8:00 AM ISTConsuming moderate amounts of coffee and caffeine regularly may offer a protective effect against developing multiple cardiometabolic diseases,...
Arsenic exposure linked to faster onset of diabetes, unravels research Dr. Kamal Kant Kohli19 Sept 2024 7:00 AM ISTExposure to arsenic and other toxic metals may accelerate the progression toward diabetes, according to a new study by University of Illinois Chicago...
Weekly Insulin Efsitora Noninferior to Daily Insulin Degludec for Type 2 Diabetes Management: Phase 3 Trial Written By Medha Baranwal19 Sept 2024 7:00 AM ISTUSA: A recent clinical trial (QWINT-2) has revealed that efsitora, a new once-weekly insulin, is as effective as the well-established once-daily...
